Back to Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 12

SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: pathophysiology, clinical outcomes, and future directions

Total article views   Abstract views HTML views PDF downloads Totals
5,024 Dovepress* 3,079 1,124+ 1,077 4,203
PubMed Central* 0 821 305 821
Totals 3,079 1,945 1,382 5,024
*Since 3 July 2019
+Since July 2016

View citations on PubMed Central and Google Scholar